SB 92

  • Georgia Senate Bill
  • 2021-2022 Regular Session
  • Introduced in Senate
  • Passed Senate Mar 05, 2021
  • Passed House Mar 29, 2021
  • Governor

Controlled Substances; sale to and by minors of drug products containing dextromethorphan; prohibit

Abstract

A BILL to be entitled an Act to amend Part 1 of Article 2 of Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to schedules, offenses, and penalties regarding the regulation of controlled substances, so as to prohibit the sale to and by minors of drug products containing dextromethorphan; to provide for definitions; to provide for proper identification; to provide for a list of finished drug products; to provide for penalties; to provide for statutory construction; to provide for state regulation; to provide for limited liability; to provide for related matters; to provide an effective date and applicability; to repeal conflicting laws; and for other purposes.

Bill Sponsors (5)

Votes


Actions


Mar 29, 2021

House

House Third Readers

House

House Passed/Adopted By Substitute

Mar 25, 2021

House

House Committee Favorably Reported By Substitute

  • Committee-Passage-Favorable
Judiciary Non-Civil

Mar 09, 2021

House

House Second Readers

Mar 08, 2021

House

House First Readers

Mar 05, 2021

Senate

Senate Third Read

Senate

Senate Tabled

Senate

Senate Taken from Table

Senate

Senate Passed/Adopted By Substitute

Mar 01, 2021

Senate

Senate Read Second Time

Feb 26, 2021

Senate

Senate Committee Favorably Reported By Substitute

  • Committee-Passage-Favorable
Judiciary

Feb 08, 2021

Senate

Senate Read and Referred

  • Referral-Committee
Judiciary

Feb 04, 2021

Senate

Senate Hopper

Bill Text

Bill Text Versions Format
LC 33 8820S/hss PDF
As passed Senate PDF
Committee sub LC 41 3018S PDF
As introduced LC 28 0070 PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Georgia General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.